COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/
As listed in the register: COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 microgrammes)/dose, dispersion à diluer pour dispersion injectable. Vaccin à ARNm (à nucléoside modifié) contre la COVID-19
5 microgrammes + 5 microgrammes · dispersion à diluer pour dispersion injectable
- Prescription only
- Active substance
- Famtozinaméran + Tozinaméran
- Made by
- BIONTECH MANUFACTURING (ALLEMAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | BIONTECH MANUFACTURING (ALLEMAGNE) |
|---|---|
| Active substance | Famtozinaméran + Tozinaméran |
| Strength | 5 microgrammes + 5 microgrammes |
| Form | dispersion à diluer pour dispersion injectable |
| Route | intramusculaire |
| Dispensing (as stated by the register) | liste I |
| Marketed | No — authorised but not currently marketed, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/20/1528 |
| Name in the register | COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 microgrammes)/dose, dispersion à diluer pour dispersion injectable. Vaccin à ARNm (à nucléoside modifié) contre la COVID-19 |
| Packs | 10 flacon(s) multidose(s) en verre de 10 dose(s) ( abrogée le 12/12/2024) |
| CIS | 64089816 |
| CIP13 | 3400930264478 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.